Abstract
Structures and sugar binding by members of two lectin families, CVNH and OAAH, were determined to elucidate the basis for recognition of high-mannose glycans on the HIV envelope glycoprotein gp120. We solved NMR solution and/or crystal structures for several lectins and delineated their carbohydrate specificity by array screening and direct NMR titrations. Both families recognize different epitopes on high-mannose glycans, namely Manα(1–2)Man units at the ends of the D1 and D3 arms and α3,α6-mannopentaose at the central branch point of Man-8 or Man-9 for CVNH and OAAH lectins, respectively.
Introduction
Lectins, carbohydrate-binding proteins, are central players in numerous important cellular functions, such as cell-cell adhesion, trafficking of glycoproteins, glycosylation and many more (Sharon, 2008; Sharon and Lis, 1989, 2004). Unfortunately, for a large number of events, the underlying carbohydrate-mediated mechanisms are not fully elucidated, given their intricate nature. As an example of the complexity involved, one only needs to consider eukaryotic protein glycosylation such as human mucin-type O-glycosylation: this is carried out by a highly sophisticated enzymatic machinery composed of 20 different isoenzymes (Hassan et al., 2000; Ten Hagen et al., 2003).
Compared to oligonucleotides or polypeptides, the combinatorial possibilities of oligosaccharides are several orders of magnitude greater. Two possible anomeric configurations (α/β), different linkages (1–2, 1–3, 1–4, 1–6), different ring sizes (pyranose/furanose), as well as diverse branching points are possible; in addition, modification through acetylation, phosphorylation and sulfation also occurs (Herget et al., 2008; Marino et al., 2010; Richards and Lowary, 2009; Varki, 2009). Thus, an enormous level of diversity can potentially be explored in protein-carbohydrate interactions.
Structure and glycan binding of CV-N and single-domain CVNHs
CV-N is a small (11 kDa) virucidal lectin originally identified in aqueous extracts from the cyanobacterium Nostoc ellipsosporum during screening for anti-HIV activities (Boyd et al., 1997). The sequence of CV-N comprises two tandem repeats, each containing ~50 amino acids and two pairs of disulphide-bonded cysteines. The structure of CV-N exhibits pseudosymmetry with two distinct domains, A and B (Fig. 1A) (Bewley et al., 1998; Yang et al., 1999). One sugar binding site was identified on each domain by NMR titration experiments (Barrientos and Gronenborn, 2002; Barrientos et al., 2006; Matei et al., 2008; Shenoy et al., 2002): a shallow cleft on domain A and a somewhat deeper pocket in domain B, with both sites separated by ~ 40 Å at opposite ends of the molecule (Fig. 1B). The anti-HIV activity of CV-N is mediated via interactions between the protein and α(1–2) linked mannose units on the terminal arms of the branched Man-8 and Man-9 structures on gp120 (Barrientos et al., 2003; Botos et al., 2002; Shenoy et al., 2002; Shenoy et al., 2001).
Figure 1. Structures and sequence alignment of CVNH family members.
(A) – (B) Structure (A) and location of two sugar binding sites on CV-N (B). (C) – (F) Solution structures and location of sugar binding sites for four new members of the CVNH family; TbCVNH (C), CrCVNH (D), NcCVNH (E), and GzCVNH (F). Note that domain A is colored in white for all structures while domain B is colored in blue, purple, light green, light blue, and light magenta for CV-N, TbCVNH, CrCVNH, NcCVNH, and GzCVNH, respectively. (G) Amino acid sequence alignment for five members of the CVNH family studied in our laboratory. The first and second sequence repeats are displayed in the upper and lower panel, respectively. Black brackets indicate the location of the disulphide bridges between cysteines in CV-N and all corresponding residues in the other sequences are boxed.
The NMR solution structure of the CV-N-Manα-(1–2)-Manα complex was solved using protein and carbohydrate at 1:1 and 1:2 molar ratios (Bewley 2001). Intra- and inter molecular NOEs for the protein alone and for Manα-(1–2)-Manα in the complex were extracted from 3D 15N separated and 12C filtered NOESY and 3D 12C filtered/13C separated NOESY spectra, and the complex structure was calculated using a procedure where backbone and non-interfacial side chains of CVN were fixed, while the interfacial side chains of the protein and Manα-(1–2)-Manα were free to move, subject to the restraints (Bewley 2001).
As part of a project aimed at understanding structure-function relationships in a family of CV-N homologous proteins, collectively designated as CVNHs, NMR solution structures of T. borchii, C. richardii, N. crassa and G. zea CVNHs were determined (Fig. 1C–1F, respectively). These proteins were selected as representative members of the CVNH family, residing on different branches of the phylogenetic tree. (Koharudin et al., 2008; Matei et al., 2011; Percudani et al., 2005). All proteins exhibit the same fold and the overall structures resemble that of the founding member of the family, CV-N, albeit with noteworthy differences in loop conformation and detailed local structure. In addition, a number of distinct features are present in these related sequences and structures. For example (Fig. 1G), in fungal but not fern homologs, Cys residues corresponding to the two S-S bonds of CVN are absent and equivalent S-S bonds to those in CV-N (between C8-C22 and C58-C73) are only found in CrCVNH (between C9-C23 and C59-C74), with an additional disulphide bond between C3 and C102. For the other three proteins, TbCVNH, NcCVNH and GzCVNH, no S-S bridges are observed. In TbCVNH and GzCVNH, only one Cys residue corresponding to C22 of CV-N is conserved. The other Cys residues are replaced by S7 (CV-N C8), S/A59 (CV-N C58) and P/L75 (CV-N C73). One Cys is present at position 72 in TbCVNH and position 101 in GzCVNH. However, given that no possible interacting Cys side chains are found spatially close to position 58 or 101, no disulphide bond can be formed. In NcCVNH, all corresponding Cys are replaced by hydrophobic residues (Ala at positions 7/61 and Leu at positions 25/82).
Extensive carbohydrate binding studies were conducted by glycan-array and NMR screening and the ligand binding sites on all four proteins were identified by chemical shift perturbation studies (Koharudin et al., 2008; Matei et al., 2011). The number and location of binding sites vary for the four proteins and different ligand specificities exist (Fig. 1A – 1F). In CrCVNH, like in CV-N, two carbohydrate binding sites are present, one each on domain A and B, whereas TbCVNH contains only a single binding site on domain A. Both, NcCVNH and GzCVNH, possess a single binding site on domain B. CV-N and NcCVNH interact with several high mannose glycans, while TbCVNH, binds only tetra- and penta-mannose. Unique among the examined proteins, TbCVNH was found to also bind linear, mannose-lacking sugars made up of glucose only, or a combination of glucose, galactose and N-acetyl glucosamine connected by β-linkages. Thus, TbCVNH is the most promiscuous lectin in the CVNH family.
Structure and glycan binding of a multi-domain CVNH
Based on their domain organization, CVNHs have been grouped into three categories: type I proteins contain either single or multiple CVNH domains, each composed of tandem-sequence repeats; type II are multi-domain proteins which, in addition to the CVNH domain sequence, also contain an MS8 domain of unknown function; and type III proteins comprise interrupted CVNH domains, in which another domain sequence is inserted between individual repeats in a single CVNH domain sequence (Percudani et al., 2005). For type III proteins, it was not clear, a priori, whether the characteristic fold of the CVNH domain would be retained, given the interruption in the sequence by the insertion.
The rice blast fungus Magnaporthe oryzae’s genome encodes a protein, containing a type III CVNH lectin, in which a LysM domain is inserted into the single CVNH module (Percudani et al., 2005). LysM domains are found in many modular bacterial and fungal enzymes involved in cell wall degradation and the domain was originally described for a lysozyme from the Bacillus phage phi 29 (Garvey et al., 1986; Saedi et al., 1987). Two nine-residue-long linkers connect the end of the first CVNH repeat to the N-terminal residue of the LysM domain, while the other joins the C-terminus of the LysM domain to the first amino acid of the second CVNH repeat. The NMR solution structure of MoCVNH-LysM revealed that the two domains are flexibly connected, lacking a fixed orientation between them (Koharudin et al., 2011) (Fig. 2A). The architecture of the individual domains closely resembles those of previously determined structures of CVNH and LysM domains, and the connections exhibit mobile, random-coil conformations. The fact that the domains behave as two independent units, rather than a single one, was evidenced by several pieces of data: (i) no NOEs were observed between residues in the linker regions and either of the two domains, and (ii) heteronuclear NOE relaxation data for the linker residues (hetNOE ~ 0.13 to 0.51) indicate substantial motion, compared to residues located in either domain, and (iii) the correlation times of the domains in the linked construct are very similar to those in their isolated counterparts.
Figure 2. Structure and carbohydrate specificity of MoCVNH-LysM.
(A) Ribbon representation of the full-length MoCVNH-LysM structure. Domains A and B of the CVNH domain are colored in white and light yellow, respectively. The LysM domain is colored in blue. The two flexible linkers are colored orange. (B) Interaction of MoCVNH-LysM with Manα(1–2)Man. The 1H-15N HSQC spectra without and with excess Manα(1–2)Man at the final point in the titration (~51 molar excess) are colored in black and cyan, respectively. Apparent binding constants (Kd) of 5.23 ± 0.42 mM and 15.13 ± 1.13 mM were extracted from the binding isotherms for sub-domains A and B, respectively, using resonances of four residues in each sub-domain (inserts). (C) Interaction of MoCVNH-LysM with the (N-GlcNAc)5 pentasaccharide. The 1H-15N HSQC spectra without and with excess (N-GlcNAc)5 pentasaccharide are colored in black and magenta, respectively. Similar to (B), an apparent Kd was extracted from the binding isotherms of five bound amide resonances, yielding a value of ~28 ± 3 μM.
MoCVNH-LysM binds oligo-mannose (via the CVNH domain) and oligo-N-GlcNAc (via the LysM domain) carbohydrates with millimolar and micromolar affinities, respectively (Koharudin et al., 2011) (Fig. 2B). The latter are the building blocks of chitin, a major constituent of fungal cell walls. In addition, binding of the peptidoglycan component N-GlcNAc-β-(1,4)-N-MurNAc is also observed (Fig. 2C). This strongly suggests that a chitin-related and oligomannose-containing polysaccharide may be the physiological ligand of this dual-domain lectin.
Structure and glycan binding of members of the OAAH family
Another anti-HIV lectin, named Oscillatory Agardhii Agglutinin (OAA) was recently discovered in the cyanobacterium Oscillatory Agardhii (Sato and Hori, 2009; Sato et al., 2000). Its gene sequence permitted placement into a phylogenetic tree composed of eight other homologous hypothetical proteins (Sato and Hori, 2009; Sato et al., 2007). We determined crystal structures of the OA lectin as well as that of a homolog from Pseudomonas fluorescens. The overall architecture of OAA and PFA is a compact β-barrel made up from a continuous ten-stranded, anti-parallel β-sheet (Fig. 3A–3B, respectively). Each of the amino acid sequence repeats folds into five β-strands, β1 to β5, (colored in grey and green for OAA and PFA, respectively, and β6 to β10 (colored in light blue and purple for OAA and PFA, respectively). The two sequence repeats are connected by a very short linker, comprising residues G67-N69 (colored in orange).
Figure 3. Overall architecture and carbohydrate binding specificity of OAA and PFA.
(A) and (B) Crystal structures of OAA and PFA determined at 1.55 and 1.70 Å, respectively. The first five β-strands, β1 to β5, are colored in grey and green, and the next β-strands, β6 to β10, are colored in light blue and purple for OAA and PFA, respectively. The two sets of five β-strands are connected by a short linker, comprising residues G67-N69 in both structures (colored in orange). (C) – (F) 1H-15N HSQC spectra of OAA (C) and PFA (D) and chemical shift mapping of α3,α6-mannopentaose binding to OAA (E) and PFA (F). The titrations were carried out using 0.040 mM OAA or PFA in 20 mM NaAcetate, 20 mM NaCl, 3 mM NaN3, 90/10% H2O/D2O (pH 5.0), 25°C. (G) and (H) X-ray structures of CAPS-bound OAA (G) and α3,α6-mannopentaose-bound OAA (H), determined at 1.20 and 1.60 Å, respectively. (I) and (J) Surface representations of OAA’s carbohydrate binding sites 1 and 2, respectively, with the bound α3,α6-mannopentaose depicted in stick representation. The β strands from the first and second sequence repeats are colored in white and light blue, respectively. Protein residues directly interacting with the sugar in each binding site are labeled by single-letter code and the sugar rings of the carbohydrate are labeled as in the Man-9 structure.
The linkers connecting strands β2 and β3, and β7 and β8, respectively, cross at the top or the bottom of the barrel and the first two β-strands of each sequence repeat (β1-β2 and β6-β7) and the next three β-strands (β3-β4-β5 and β8-β9-β10) are positioned on opposite sides of the barrel (Fig. 3A–3B). As a result, β1 and β2 in the first sequence repeat are located in the barrel between the β-strands β7 and β6 from the second repeat on one side and strands β10, β9 and β8 on the other side. Similarly, strands β3, β4 and β5 of the first repeat are flanked by β8 and β6, respectively, of the other sequence repeat. The swap of β-strands between the two sequence repeats creates an almost perfect C2 symmetric arrangement, rendering the conformation of the five β strands in each sequence repeat extremely similar. This can be easily appreciated from the backbone atomic r.m.s.d. values of 0.66 and 0.70 Å for the OAA and PFA repeats, respectively.
After resonance assignments for both proteins were complete, glycan binding was directly tested by 1H-15N HSQC NMR titrations. α3,α6-mannopentaose binding is in slow exchange on the chemical shift scale (new bound resonances appear), suggesting relatively tight binding. Titration data sets were recorded for 15N-labeled OAA and PFA, permitting for unambiguous delineation of the glycan binding sites on the proteins. In both proteins, site 1 is formed by loops between β-strands from the N- and C-terminal ends of the polypeptide (between β1/β2 and β9/β10), and site 2 comprises residues in the middle of the chain in loops between β4/β5 and β6/β7 (Fig. 3C–3F).
Initial efforts aimed at crystallizing a complex between OAA and Man-9 or α3,α6-mannopentaose (either by soaking or co-crystallization), were unsuccessful due to the presence of N-cyclohexyl-3-aminopropane-sulfonic acid (CAPS) in the crystallization buffer that resulted in two bound CAPS molecules in the crystal structure of OAA (Fig. 3G). Changing crystallization conditions and omitting CHAPS, eventually yielded new crystals of both apo- and α3,α6-mannopentaose-bound OAA in different space groups. The sugar binding pockets of site 1 and site 2 on OAA are in the same place as identified by NMR and exhibit very similar conformations (Fig. 3H). They reside between the loops on the surface of the protein. The M3α(1–6)M4’ disaccharide unit of the α3,α6-mannopentaose is most deeply imbedded in the protein (Fig. 3I–3J), with the M4α(1–3)M3 disaccharide also inside the binding pocket, while the M5’α(1–3)[M5”α(1–6)]M4’ trisaccharide unit is pointing towards solvent. The pyranose ring of M3 in the M4α(1–3)M3 unit is stacked on top of the indole ring of tryptophan side chains, W10 in site 1 and of W77 in site 2, while the pyranose ring of M4 is inserted between two arginines side chains. The pyranose ring of M5’ is flanked by residues in the loop connecting strands β1-β2 and β6-β7 in site 1 and 2, respectively, while the pyranose rings of M5’’ and M4’ are flanked by residues in the β9-β10 and β4-β5 loops for site 1 and 2, respectively.
Comparing the carbohydrate binding sites in the apo-structure and the sugar-bound X-ray structures revealed that in the free protein, the orientation of the peptide bond between W10 and G11 (binding site 1) and W77 and G78 (binding site 2) is flipped, with the carbonyl oxygens of W10 and W77 pointing in opposite directions. Upon sugar binding, the conformation in binding site 1 is essentially unchanged, i.e. the protein is already in a “bound” conformation, even in the absence of sugar, while α3,α6-mannopentaose binding to site 2 changes the orientation of the W77/G78 peptide plane from the “free” to the “bound” conformation. We, therefore, conducted extensive NMR studies at different temperatures, including measurements of relaxation data for the free and bound protein; essentially identical values for the equivalent residues were obtained, indicating that the loops associated with sugar binding are equally flexible in both sites. In addition, we explored different temperatures for X-ray data collection, since differences between the NMR and X-ray results could have been caused by ‘freezing out’ conformations at cryogenic temperatures in the crystal. None of our data suggested that in the cryogenic X-ray structure the bound conformation was fortuitously selected. We, therefore, conclude that both loop regions in the free protein are flexible and that crystal packing effects around the carbohydrate binding site 1 forces the conformation of the β1-β2 loop into the conformation seen in the carbohydrate-bound structure.
Acknowledgments
The authors are indebted to all past and present members of AMG’s group. This work is funded by the National Institutes of Health (R01GM080642).
References
- Barrientos LG, Gronenborn AM. The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution. Biochem Biophys Res Commun. 2002;298:598–602. doi: 10.1016/s0006-291x(02)02489-0. [DOI] [PubMed] [Google Scholar]
- Barrientos LG, Matei E, Lasala F, Delgado R, Gronenborn AM. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. Protein Eng Des Sel. 2006;19:525–535. doi: 10.1093/protein/gzl040. [DOI] [PubMed] [Google Scholar]
- Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus. Antiviral Res. 2003;58:47–56. doi: 10.1016/s0166-3542(02)00183-3. [DOI] [PubMed] [Google Scholar]
- Bewley CA. Solution structure of a cyanovirin-N:Man alpha 1–2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure. 2001;9:931–940. doi: 10.1016/s0969-2126(01)00653-0. [DOI] [PubMed] [Google Scholar]
- Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol. 1998;5:571–578. doi: 10.1038/828. [DOI] [PubMed] [Google Scholar]
- Botos I, O'Keefe BR, Shenoy SR, Cartner LK, Ratner DM, Seeberger PH, Boyd MR, Wlodawer A. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J Biol Chem. 2002;277:34336–34342. doi: 10.1074/jbc.M205909200. [DOI] [PubMed] [Google Scholar]
- Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother. 1997;41:1521–1530. doi: 10.1128/aac.41.7.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garvey KJ, Saedi MS, Ito J. Nucleotide sequence of Bacillus phage phi 29 genes 14 and 15: homology of gene 15 with other phage lysozymes. Nucleic Acids Res. 1986;14:10001–10008. doi: 10.1093/nar/14.24.10001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hassan H, Bennett EP, Mandel U, Hollingsworth MA, Clausen H. O-glycan occupancy is directed by substrate specificities of polypeptide GalNAc-transferases. In: Ernst B, Hart BW, Sina P, editors. Carbohydrates in Chemistry and Biology. New York: Wiley-VCH; 2000. [Google Scholar]
- Herget S, Toukach PV, Ranzinger R, Hull WE, Knirel YA, von der Lieth CW. Statistical analysis of the Bacterial Carbohydrate Structure Data Base (BCSDB): characteristics and diversity of bacterial carbohydrates in comparison with mammalian glycans. BMC Struct Biol. 2008;8:35. doi: 10.1186/1472-6807-8-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koharudin LM, Viscomi AR, Jee JG, Ottonello S, Gronenborn AM. The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity. Structure. 2008;16:570–584. doi: 10.1016/j.str.2008.01.015. [DOI] [PubMed] [Google Scholar]
- Koharudin LM, Viscomi AR, Montanini B, Kershaw MJ, Talbot NJ, Ottonello S, Gronenborn AM. Structure-function analysis of a CVNH-LysM lectin expressed during plant infection by the rice blast fungus Magnaporthe oryzae. Structure. 2011;19:662–674. doi: 10.1016/j.str.2011.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marino K, Bones J, Kattla JJ, Rudd PM. A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol. 2010;6:713–723. doi: 10.1038/nchembio.437. [DOI] [PubMed] [Google Scholar]
- Matei E, Furey W, Gronenborn AM. Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping. Structure. 2008;16:1183–1194. doi: 10.1016/j.str.2008.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matei E, Louis JM, Jee J, Gronenborn AM. NMR solution structure of a cyanovirin homolog from wheat head blight fungus. Proteins. 2011;79:1538–1549. doi: 10.1002/prot.22981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Percudani R, Montanini B, Ottonello S. The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes. Proteins. 2005;60:670–678. doi: 10.1002/prot.20543. [DOI] [PubMed] [Google Scholar]
- Richards MR, Lowary TL. Chemistry and biology of galactofuranose-containing polysaccharides. Chembiochem. 2009;10:1920–1938. doi: 10.1002/cbic.200900208. [DOI] [PubMed] [Google Scholar]
- Saedi MS, Garvey KJ, Ito J. Cloning and purification of a unique lysozyme produced by Bacillus phage phi 29. Proc Natl Acad Sci U S A. 1987;84:955–958. doi: 10.1073/pnas.84.4.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato T, Hori K. Cloning, expression, and characterization of a novel anti-HIV lectin from the cultured cyanobacterium, Oscillatoria agardhii. Fish Sci. 2009;75:743–753. [Google Scholar]
- Sato Y, Murakami M, Miyazawa K, Hori K. Purification and characterization of a novel lectin from a freshwater cyanobacterium, Oscillatoria agardhii. Comp Biochem Physiol B Biochem Mol Biol. 2000;125:169–177. doi: 10.1016/s0305-0491(99)00164-9. [DOI] [PubMed] [Google Scholar]
- Sato Y, Okuyama S, Hori K. Primary structure and carbohydrate binding specificity of a potent anti-HIV lectin isolated from the filamentous cyanobacterium Oscillatoria agardhii. J Biol Chem. 2007;282:11021–11029. doi: 10.1074/jbc.M701252200. [DOI] [PubMed] [Google Scholar]
- Sharon N. Lectins: past, present and future. Biochem Soc Trans. 2008;36:1457–1460. doi: 10.1042/BST0361457. [DOI] [PubMed] [Google Scholar]
- Sharon N, Lis H. Lectins as cell recognition molecules. Science. 1989;246:227–234. doi: 10.1126/science.2552581. [DOI] [PubMed] [Google Scholar]
- Sharon N, Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology. 2004;14:53R–62R. doi: 10.1093/glycob/cwh122. [DOI] [PubMed] [Google Scholar]
- Shenoy SR, Barrientos LG, Ratner DM, O'Keefe BR, Seeberger PH, Gronenborn AM, Boyd MR. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization. Chem Biol. 2002;9:1109–1118. doi: 10.1016/s1074-5521(02)00237-5. [DOI] [PubMed] [Google Scholar]
- Shenoy SR, O’Keefe BR, Bolmstedt AJ, Cartner LK, Boyd MR. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins. J Pharmacol Exp Ther. 2001;297:704–710. [PubMed] [Google Scholar]
- Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology. 2003;13:1R–16R. doi: 10.1093/glycob/cwg007. [DOI] [PubMed] [Google Scholar]
- Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J. 2009;26:231–245. doi: 10.1007/s10719-008-9183-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang F, Bewley CA, Louis JM, Gustafson KR, Boyd MR, Gronenborn AM, Clore GM, Wlodawer A. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol. 1999;288:403–412. doi: 10.1006/jmbi.1999.2693. [DOI] [PubMed] [Google Scholar]



